EV/EBITDA
-1.44
0.000.00%
Wed, 05 Mar 2025 23:08:14 GMT
Summary
- As of March 6, 2025, CHRO EV/EBITDA is -1.44, unchanged from the previous trading day.
- Over the past year, CHRO EV/EBITDA has increased by +1.48 (+50.68%).
- CHRO EV/EBITDA is now -311.43% below its all-time high of -0.35.
Performance
CHRO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CHRO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | 0.0% | 0.0% |
| 1 m1 month | -28.6% | +28.5% | +31.6% |
| 3 m3 months | -188.0% | +185.2% | +235.6% |
| 6 m6 months | -220.0% | +242.2% | +163.1% |
| ytdytd | -188.0% | +184.7% | +234.8% |
| 1 y1 year | +50.7% | -31.2% | -32.4% |
| 5 y5 years | - | - | - |
CHRO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -63.6% | -1.50 | +4.0% | |
| 3 m | 3-month | -0.46 | -213.0% | -1.83 | +21.3% |
| 6 m | 6-month | -0.39 | -269.2% | -1.83 | +21.3% |
| 1 y | 1-year | -0.35 | -311.4% | -3.21 | +55.1% |
| 3 y | 3-year | -0.35 | -311.4% | -4.21 | +65.8% |
| 5 y | 5-year | -0.35 | -311.4% | -4.21 | +65.8% |
| alltime | all time | -0.35 | -311.4% | -4.21 | +65.8% |
Chromocell Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.44(+188.0%) |
| Date | Value |
|---|---|
| 2024 | -0.50 |
FAQ
- What is Chromocell Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Chromocell Therapeutics?
- What is CHRO EV/EBITDA year-to-date change?
- What is Chromocell Therapeutics EV/EBITDA year-on-year change?
What is Chromocell Therapeutics EV/EBITDA?
The current EV/EBITDA of CHRO is -1.44
What is the all time high EV/EBITDA for Chromocell Therapeutics?
Chromocell Therapeutics all-time high EV/EBITDA is -0.35
What is CHRO EV/EBITDA year-to-date change?
Chromocell Therapeutics EV/EBITDA has changed by -0.94 (-188.00%) since the beginning of the year
What is Chromocell Therapeutics EV/EBITDA year-on-year change?
Over the past year, CHRO EV/EBITDA has changed by +1.48 (+50.68%)